Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits - PubMed (original) (raw)
Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits
W Palinski et al. Arterioscler Thromb Vasc Biol. 1995 May.
Abstract
Atherosclerosis is known to be accelerated in diabetic patients, but the mechanisms of this acceleration are poorly understood. Nonenzymatic glycosylation of long-lived proteins results in the formation of advanced glycosylation end products (AGEs), which are extensively cross-linked and could contribute to atherogenesis. Oxidative modification of LDL is also an important process in atherogenesis. In vitro evidence suggests that hyperglycemia may enhance lipid peroxidation, and conversely, that increased lipid peroxidation may enhance AGE formation. If such interactions occur in vivo, we hypothesized that AGE should be found in atherosclerotic lesions of euglycemic LDL receptor-deficient rabbits in areas rich in lipids and oxidized lipoproteins. To demonstrate the presence of AGEs, we developed antisera against a specific "model" compound of AGE, 2-furoyl-4(5)-(2-furanyl)-1H-imidazole (FFI) by using FFI-hexanoic acid (FFI-HA)-protein adducts as the antigen and against AGEs in general by using AGE-albumin as the antigen. Antisera generated with FFI-HA-protein adducts recognized FFI-HA alone as well as FFI-protein adducts. Native proteins or proteins conjugated with aldehydes formed during lipid peroxidation in vitro were not recognized by these antisera. Immunocytochemistry with both FFI-specific and AGE-specific antisera revealed the presence of these epitopes in atherosclerotic lesions of euglycemic LDL receptor-deficient rabbits but not in normal aortic tissues. AGE epitopes within atherosclerotic lesions were predominantly found in similar locations as epitopes generated during modification of the lipoproteins by oxidation, consistent with the hypothesized interactions between oxidation and glycosylation. Indirect evidence in support of the in vivo presence of FFI-like structures was also obtained by the observation that both diabetic and euglycemic human subjects contained autoantibodies that recognize FFI-protein adducts. Taken together, these data provide immunological evidence for the in vivo presence of FFI-like structures and other AGE-protein adducts in atherosclerotic lesions, even in euglycemic conditions.
Similar articles
- In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
Imanaga Y, Sakata N, Takebayashi S, Matsunaga A, Sasaki J, Arakawa K, Nagai R, Horiuchi S, Itabe H, Takano T. Imanaga Y, et al. Atherosclerosis. 2000 Jun;150(2):343-55. doi: 10.1016/s0021-9150(99)00396-2. Atherosclerosis. 2000. PMID: 10856526 - Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.
Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takebayashi S, Nagai R, Horiuchi S, Itabe H, Takano T. Sakata N, et al. Atherosclerosis. 1998 Nov;141(1):61-75. doi: 10.1016/s0021-9150(98)00149-x. Atherosclerosis. 1998. PMID: 9863539 - ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum.
Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL. Palinski W, et al. Arterioscler Thromb. 1994 Apr;14(4):605-16. doi: 10.1161/01.atv.14.4.605. Arterioscler Thromb. 1994. PMID: 7511933 - What is the effect of hyperglycemia on atherogenesis and can it be reversed by aminoguanidine?
Bucala R. Bucala R. Diabetes Res Clin Pract. 1996 Feb;30 Suppl:123-30. doi: 10.1016/s0168-8227(96)80048-9. Diabetes Res Clin Pract. 1996. PMID: 8964186 Review. - Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions.
Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, Thorpe SR. Requena JR, et al. Nephrol Dial Transplant. 1996;11 Suppl 5:48-53. doi: 10.1093/ndt/11.supp5.48. Nephrol Dial Transplant. 1996. PMID: 9044307 Review.
Cited by
- Stimulatory effects of advanced glycation endproducts (AGEs) on fibronectin matrix assembly.
Pastino AK, Greco TM, Mathias RA, Cristea IM, Schwarzbauer JE. Pastino AK, et al. Matrix Biol. 2017 May;59:39-53. doi: 10.1016/j.matbio.2016.07.003. Epub 2016 Jul 15. Matrix Biol. 2017. PMID: 27425255 Free PMC article. - Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.
Lyons TJ, Jenkins AJ. Lyons TJ, et al. Diabetes Rev (Alex). 1997;5(4):365-391. Diabetes Rev (Alex). 1997. PMID: 26366051 Free PMC article. - Infrared microspectroscopy identifies biomolecular changes associated with chronic oxidative stress in mammary epithelium and stroma of breast tissues from healthy young women: implications for latent stages of breast carcinogenesis.
Patel II, Shearer DA, Fogarty SW, Fullwood NJ, Quaroni L, Martin FL, Weisz J. Patel II, et al. Cancer Biol Ther. 2014 Feb;15(2):225-35. doi: 10.4161/cbt.26748. Epub 2013 Nov 1. Cancer Biol Ther. 2014. PMID: 24107651 Free PMC article. - Maternal immunization affects in utero programming of insulin resistance and type 2 diabetes.
Eberle C, Merki E, Yamashita T, Johnson S, Armando AM, Quehenberger O, Napoli C, Palinski W. Eberle C, et al. PLoS One. 2012;7(9):e45361. doi: 10.1371/journal.pone.0045361. Epub 2012 Sep 18. PLoS One. 2012. PMID: 23028961 Free PMC article. - Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids.
Gauba V, Grünewald J, Gorney V, Deaton LM, Kang M, Bursulaya B, Ou W, Lerner RA, Schmedt C, Geierstanger BH, Schultz PG, Ramirez-Montagut T. Gauba V, et al. Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12821-6. doi: 10.1073/pnas.1110042108. Epub 2011 Jul 18. Proc Natl Acad Sci U S A. 2011. PMID: 21768354 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical